Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Jeff Warburton is active.

Publication


Featured researches published by Jeff Warburton.


The Journal of Clinical Psychiatry | 2014

An exploratory randomized controlled study of a healthy living intervention in early intervention services for psychosis: the INTERvention to encourage ACTivity, improve diet, and reduce weight gain (INTERACT) study.

Karina Lovell; Alison Wearden; Tim Bradshaw; Barbara Tomenson; Rebecca Pedley; Linda Davies; Nusrat Husain; Adrine Woodham; Diane Escott; Caroline Swarbrick; Omolade Femi-Ajao; Jeff Warburton; Max Marshall

BACKGROUND People with psychosis often experience weight gain, which places them at risk of cardiovascular disease, diabetes, and early death. OBJECTIVE To determine the uptake, adherence, and clinical effectiveness of a healthy living intervention designed to reduce weight gain. METHOD An exploratory randomized controlled trial, comparing the intervention with treatment as usual (TAU) in 2 early intervention services for psychosis in England. DSM-IV classification was the diagnostic criteria used to assign the psychiatric diagnoses. The primary outcome was change in body mass index (BMI) from baseline to 12-month follow-up. The study was conducted between February 2009 and October 2012. RESULTS 105 service users, with a BMI of ≥ 25 (≥ 24 in South Asians), were randomized to intervention (n = 54) or TAU (n = 51) after stratification by recent commencement of antipsychotic medication. Ninety-three service users (89%) were followed up at 12 months. Between-group difference in change in BMI was not significant (effect size = 0.11). The effect of the intervention was larger (effect size = 0.54, not significant) in 15 intervention (28%) and 10 TAU (20%) participants who were taking olanzapine or clozapine at randomization. CONCLUSIONS The healthy living intervention did not show a significant difference in BMI reduction compared to the TAU group. TRIAL REGISTRATION www.isrctn.org identifier: ISRCTN22581937.


Psychological Medicine | 2014

A phase-specific psychological therapy for people with problematic cannabis use following a first episode of psychosis: a randomized controlled trial

Christine Barrowclough; Max Marshall; Lynsey Gregg; M. Fitzsimmons; Barbara Tomenson; Jeff Warburton; Fiona Lobban

BACKGROUND Cannabis use is high amongst young people who have recently had their first episode of psychosis, and is associated with worse outcomes. To date, interventions to reduce cannabis consumption have been largely ineffective, and it has been suggested that longer treatment periods are required. METHOD In a pragmatic single-blind randomized controlled trial 110 participants were randomly allocated to one of three conditions: a brief motivational interviewing and cognitive behavioural therapy (MI-CBT) intervention (up to 12 sessions over 4.5 months) with standard care from an early intervention service; a long MI-CBT intervention (up to 24 sessions over 9 months) with standard care; or standard care alone. The primary outcome was change in cannabis use as measured by Timeline Followback. RESULTS Neither the extended nor the brief interventions conferred benefit over standard care in terms of reductions in frequency or amount of cannabis use. Also the interventions did not result in improvements in the assessed clinical outcomes, including symptoms, functioning, hospital admissions or relapse. CONCLUSIONS Integrated MI and CBT for people with cannabis use and recent-onset psychosis does not reduce cannabis use or improve clinical outcomes. These findings are consistent with those in the published literature, and additionally demonstrate that offering a more extended intervention does not confer any advantage. Many participants were not at an action stage for change and for those not ready to reduce or quit cannabis, targeting associated problems rather than the cannabis use per se may be the best current strategy for mental health services to adopt.


Psychological Medicine | 2014

A naturalistic, randomized, controlled trial combining cognitive remediation with cognitive-behavioural therapy after first-episode non-affective psychosis.

Richard Drake; Christine Day; R. Picucci; Jeff Warburton; W. Larkin; Nusrat Husain; Clare Reeder; Til Wykes; M. Marshall


International Journal of Nursing Studies | 2012

Developing a healthy living intervention for people with early psychosis using the Medical Research Council's guidelines on complex interventions: phase 1 of the HELPER - InterACT programme

Tim Bradshaw; Alison Wearden; Max Marshall; Jeff Warburton; Nusrat Husain; Rebecca Pedley; Diane Escott; Caroline Swarbrick; Karina Lovell


Programme Grants for Applied Research | 2015

The HELPER programme : HEalthy Living and Prevention of Early Relapse – three exploratory randomised controlled trials of phase-specific interventions in first-episode psychosis

Max Marshall; Christine Barrowclough; Richard Drake; Nusrat Husain; Fiona Lobban; Karina Lovell; Alison Wearden; Tim Bradshaw; Christine Day; Mike Fitzsimmons; Rebecca Pedley; Ruth Piccuci; Alicia Picken; Warren Larkin; Barbara Tomenson; Jeff Warburton; Lynsey Gregg


Archive | 2015

The InterACT trial healthy living intervention booklet

Max Marshall; Christine Barrowclough; Richard Drake; Nusrat Husain; Fiona Lobban; Karina Lovell; Alison Wearden; Tim Bradshaw; Christine Day; Mike Fitzsimmons; Rebecca Pedley; Ruth Piccuci; Alicia Picken; Warren Larkin; Barbara Tomenson; Jeff Warburton; Lynsey Gregg


Archive | 2015

The Rethinking Choices After Psychosis (ReCAP) trial psychoeducational materials

Max Marshall; Christine Barrowclough; Richard Drake; Nusrat Husain; Fiona Lobban; Karina Lovell; Alison Wearden; Tim Bradshaw; Christine Day; Mike Fitzsimmons; Rebecca Pedley; Ruth Piccuci; Alicia Picken; Warren Larkin; Barbara Tomenson; Jeff Warburton; Lynsey Gregg


Archive | 2015

The InterACT trial service user interview topic guide

Max Marshall; Christine Barrowclough; Richard Drake; Nusrat Husain; Fiona Lobban; Karina Lovell; Alison Wearden; Tim Bradshaw; Christine Day; Mike Fitzsimmons; Rebecca Pedley; Ruth Piccuci; Alicia Picken; Warren Larkin; Barbara Tomenson; Jeff Warburton; Lynsey Gregg


Archive | 2015

The InterACT trial protocol

Max Marshall; Christine Barrowclough; Richard Drake; Nusrat Husain; Fiona Lobban; Karina Lovell; Alison Wearden; Tim Bradshaw; Christine Day; Mike Fitzsimmons; Rebecca Pedley; Ruth Piccuci; Alicia Picken; Warren Larkin; Barbara Tomenson; Jeff Warburton; Lynsey Gregg


Archive | 2015

Substance misuse workstream: the Asking about Substance use and Psychosis – Ideas, Reactions and Experiences (ASPIRE) study and the Rethinking Choices After Psychosis (ReCAP) randomised controlled trial

Max Marshall; Christine Barrowclough; Richard Drake; Nusrat Husain; Fiona Lobban; Karina Lovell; Alison Wearden; Tim Bradshaw; Christine Day; Mike Fitzsimmons; Rebecca Pedley; Ruth Piccuci; Alicia Picken; Warren Larkin; Barbara Tomenson; Jeff Warburton; Lynsey Gregg

Collaboration


Dive into the Jeff Warburton's collaboration.

Top Co-Authors

Avatar

Max Marshall

University of Manchester

View shared research outputs
Top Co-Authors

Avatar

Nusrat Husain

University of Manchester

View shared research outputs
Top Co-Authors

Avatar

Alison Wearden

University of Manchester

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Karina Lovell

University of Manchester

View shared research outputs
Top Co-Authors

Avatar

Rebecca Pedley

University of Manchester

View shared research outputs
Top Co-Authors

Avatar

Tim Bradshaw

University of Manchester

View shared research outputs
Top Co-Authors

Avatar

Lynsey Gregg

University of Manchester

View shared research outputs
Top Co-Authors

Avatar

Richard Drake

University of Manchester

View shared research outputs
Researchain Logo
Decentralizing Knowledge